RxDoctor Payments Data

Keith Dinklage, MD

Family Medicine · New Castle, INNPI 1538243498

Payments from drug & device makers

$769in general payments, 2019–2025

Across 39 payments — averaging $19.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$255
  • GSK$143
  • Lilly USA, LLC$84
  • Novo Nordisk$78
  • Pfizer$68
  • Astellas Pharma US Inc$37
  • plus $104 from 6 others

What the payments were for

  • Food & beverage$769100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$769 in reported general payments places this provider in the 55th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$22,979
Medicare patients
148
Services billed
287

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide39$48,051
OzempicSemaglutide35$45,245
FarxigaDapagliflozin Propanediol21$30,273
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$26,949
JardianceEmpagliflozin13$22,089
XareltoRivaroxaban13$12,685
Celecoxib43$2,615
Atorvastatin Calcium176$2,244
Amlodipine Besylate271$1,923
Bisoprolol-HydrochlorothiazideBisoprolol/Hydrochlorothiazide67$1,845
Gabapentin50$1,704
Ipratropium Bromide63$1,540
Pravastatin Sodium82$1,509
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide21$1,443
Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide158$1,193

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$84$48,05139 claims
Novo NordiskOzempic$78$45,24535 claims
AstraZenecaFarxiga$255$30,27321 claims
GSKTrelegy Ellipta$143$26,94918 claims
Johnson & JohnsonXarelto$26$12,68513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in New Castle

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →